vs
Side-by-side financial comparison of STEPAN CO (SCL) and UNIVERSAL INSURANCE HOLDINGS, INC. (UVE). Click either name above to swap in a different company.
STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $393.6M, roughly 1.5× UNIVERSAL INSURANCE HOLDINGS, INC.). UNIVERSAL INSURANCE HOLDINGS, INC. runs the higher net margin — 13.8% vs 3.3%, a 10.5% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -0.3%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs 1.7%).
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
New York Life Insurance Company (NYLIC), most commonly known as New York Life, is the second-largest life insurance company and the largest mutual life insurance company in the United States, and is ranked #69 on the 2025 Fortune 500 list of the largest U.S. corporations by total revenue. In 2025, NYLIC achieved the best possible ratings by the four independent rating companies. Other New York Life affiliates provide an array of securities products and services, as well as institutional and r...
SCL vs UVE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $604.5M | $393.6M |
| Net Profit | $19.7M | $54.3M |
| Gross Margin | 10.7% | — |
| Operating Margin | 4.7% | — |
| Net Margin | 3.3% | 13.8% |
| Revenue YoY | 1.9% | -0.3% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.86 | $1.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $604.5M | $393.6M | ||
| Q4 25 | $553.9M | $407.9M | ||
| Q3 25 | $590.3M | $401.0M | ||
| Q2 25 | $594.7M | $400.1M | ||
| Q1 25 | $593.3M | $394.9M | ||
| Q4 24 | $525.6M | $384.8M | ||
| Q3 24 | $546.8M | $387.6M | ||
| Q2 24 | $556.4M | $380.2M |
| Q1 26 | $19.7M | $54.3M | ||
| Q4 25 | $5.0M | $66.6M | ||
| Q3 25 | $10.8M | $39.8M | ||
| Q2 25 | $11.3M | $35.1M | ||
| Q1 25 | $19.7M | $41.4M | ||
| Q4 24 | $3.4M | $6.0M | ||
| Q3 24 | $23.6M | $-16.2M | ||
| Q2 24 | $9.5M | $35.4M |
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.3% | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | 12.1% | — | ||
| Q1 25 | 12.7% | — | ||
| Q4 24 | 10.8% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 12.5% | — |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 1.9% | 21.7% | ||
| Q3 25 | 3.7% | 13.2% | ||
| Q2 25 | 3.0% | 11.6% | ||
| Q1 25 | 4.8% | 14.0% | ||
| Q4 24 | 1.5% | 1.9% | ||
| Q3 24 | 4.4% | -4.7% | ||
| Q2 24 | 3.4% | 12.6% |
| Q1 26 | 3.3% | 13.8% | ||
| Q4 25 | 0.9% | 16.3% | ||
| Q3 25 | 1.8% | 9.9% | ||
| Q2 25 | 1.9% | 8.8% | ||
| Q1 25 | 3.3% | 10.5% | ||
| Q4 24 | 0.6% | 1.6% | ||
| Q3 24 | 4.3% | -4.2% | ||
| Q2 24 | 1.7% | 9.3% |
| Q1 26 | $0.86 | $1.88 | ||
| Q4 25 | $0.22 | $2.29 | ||
| Q3 25 | $0.47 | $1.38 | ||
| Q2 25 | $0.50 | $1.21 | ||
| Q1 25 | $0.86 | $1.44 | ||
| Q4 24 | $0.14 | $0.23 | ||
| Q3 24 | $1.03 | $-0.57 | ||
| Q2 24 | $0.42 | $1.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $595.8M |
| Total DebtLower is stronger | $328.4M | — |
| Stockholders' EquityBook value | $1.2B | $584.7M |
| Total Assets | $2.3B | $2.8B |
| Debt / EquityLower = less leverage | 0.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $595.8M | ||
| Q4 25 | $132.7M | $408.9M | ||
| Q3 25 | $118.5M | $405.1M | ||
| Q2 25 | $88.9M | $367.1M | ||
| Q1 25 | $107.5M | $398.2M | ||
| Q4 24 | $99.7M | $259.4M | ||
| Q3 24 | $147.3M | $333.7M | ||
| Q2 24 | $124.7M | $283.3M |
| Q1 26 | $328.4M | — | ||
| Q4 25 | $626.7M | $100.5M | ||
| Q3 25 | $655.5M | $100.7M | ||
| Q2 25 | $658.0M | $100.9M | ||
| Q1 25 | $659.3M | $101.1M | ||
| Q4 24 | $625.4M | $101.2M | ||
| Q3 24 | $688.5M | $101.4M | ||
| Q2 24 | $657.1M | $101.6M |
| Q1 26 | $1.2B | $584.7M | ||
| Q4 25 | $1.2B | $551.0M | ||
| Q3 25 | $1.2B | $495.0M | ||
| Q2 25 | $1.2B | $457.8M | ||
| Q1 25 | $1.2B | $422.4M | ||
| Q4 24 | $1.2B | $373.3M | ||
| Q3 24 | $1.2B | $400.2M | ||
| Q2 24 | $1.2B | $393.2M |
| Q1 26 | $2.3B | $2.8B | ||
| Q4 25 | $2.4B | $2.8B | ||
| Q3 25 | $2.4B | $3.1B | ||
| Q2 25 | $2.4B | $3.3B | ||
| Q1 25 | $2.4B | $2.7B | ||
| Q4 24 | $2.3B | $2.8B | ||
| Q3 24 | $2.4B | $2.7B | ||
| Q2 24 | $2.3B | $2.7B |
| Q1 26 | 0.28× | — | ||
| Q4 25 | 0.50× | 0.18× | ||
| Q3 25 | 0.53× | 0.20× | ||
| Q2 25 | 0.53× | 0.22× | ||
| Q1 25 | 0.55× | 0.24× | ||
| Q4 24 | 0.53× | 0.27× | ||
| Q3 24 | 0.56× | 0.25× | ||
| Q2 24 | 0.55× | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
UVE
Segment breakdown not available.
